Valeant Pharmaceuticals (VRX) is down 14%, Biogen (BIIB) is down 12.3%. I guess it goes without saying that Bill Ackman is having another lousy day. The weakness in biotech is keeping the Nasdaq from experiencing a rally of any sorts today, despite the Dow, SPX, Rut all on solid ground. ackman funny stuff

So where does that leave biotech going forward? I take a look at IBB – the iShares Nasdaq Biotechnology Index to break it down for you. 

There is a clear level of support underneath, but more importantly is the downtrend that is converging with the base resistance. Break these two levels at around $290, and you likely have a rally that could go as high as $340. 

Obviously that is huge for biotech stocks, and in doing so would help the entire market make that run towards new all-time highs and beyond. 

Here’s what I’m looking at:

ibb trades

    You are unauthorized to view this page.

You Might Like

  • Stop Trying to Hit Home Runs: Start Trading Within Your Means

  • How to Trade Breakouts Without Getting Trapped

  • Managing Headline Risk: How to Survive the News Cycle Without Losing Your Mind